nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—CYP2B6—malignant glioma	0.406	0.551	CbGaD
Irinotecan—BCHE—malignant glioma	0.332	0.449	CbGaD
Irinotecan—Acute leukaemia—Carmustine—malignant glioma	0.00477	0.0434	CcSEcCtD
Irinotecan—Acute leukaemia—Temozolomide—malignant glioma	0.00461	0.042	CcSEcCtD
Irinotecan—Cerebral infarction—Carmustine—malignant glioma	0.00418	0.0381	CcSEcCtD
Irinotecan—Lung infiltration—Carmustine—malignant glioma	0.0029	0.0265	CcSEcCtD
Irinotecan—Lymphopenia—Temozolomide—malignant glioma	0.00257	0.0234	CcSEcCtD
Irinotecan—Febrile neutropenia—Carmustine—malignant glioma	0.00226	0.0206	CcSEcCtD
Irinotecan—Febrile neutropenia—Temozolomide—malignant glioma	0.00219	0.0199	CcSEcCtD
Irinotecan—Embolism—Temozolomide—malignant glioma	0.00205	0.0187	CcSEcCtD
Irinotecan—Hypokinesia—Carmustine—malignant glioma	0.00202	0.0184	CcSEcCtD
Irinotecan—Thrombosis—Carmustine—malignant glioma	0.00192	0.0175	CcSEcCtD
Irinotecan—Lung disorder—Temozolomide—malignant glioma	0.00186	0.0169	CcSEcCtD
Irinotecan—Speech disorder—Carmustine—malignant glioma	0.00158	0.0144	CcSEcCtD
Irinotecan—Extravasation—Carmustine—malignant glioma	0.00156	0.0142	CcSEcCtD
Irinotecan—TOP1—retina—malignant glioma	0.00155	0.0426	CbGeAlD
Irinotecan—Accidental injury—Carmustine—malignant glioma	0.00154	0.014	CcSEcCtD
Irinotecan—TOP1MT—central nervous system—malignant glioma	0.00154	0.0422	CbGeAlD
Irinotecan—Speech disorder—Temozolomide—malignant glioma	0.00153	0.0139	CcSEcCtD
Irinotecan—TOP1MT—cerebellum—malignant glioma	0.0015	0.0413	CbGeAlD
Irinotecan—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00145	0.0132	CcSEcCtD
Irinotecan—TOP1—telencephalon—malignant glioma	0.00143	0.0392	CbGeAlD
Irinotecan—CES2—retina—malignant glioma	0.00141	0.0387	CbGeAlD
Irinotecan—Gait disturbance—Carmustine—malignant glioma	0.0014	0.0127	CcSEcCtD
Irinotecan—Pulmonary embolism—Carmustine—malignant glioma	0.00136	0.0124	CcSEcCtD
Irinotecan—Gait disturbance—Temozolomide—malignant glioma	0.00135	0.0123	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00132	0.012	CcSEcCtD
Irinotecan—Pulmonary embolism—Temozolomide—malignant glioma	0.00132	0.012	CcSEcCtD
Irinotecan—CES2—telencephalon—malignant glioma	0.00129	0.0356	CbGeAlD
Irinotecan—Neoplasm—Carmustine—malignant glioma	0.00123	0.0112	CcSEcCtD
Irinotecan—TOP1MT—brain—malignant glioma	0.00122	0.0335	CbGeAlD
Irinotecan—Neoplasm—Temozolomide—malignant glioma	0.00119	0.0108	CcSEcCtD
Irinotecan—Sepsis—Carmustine—malignant glioma	0.00118	0.0108	CcSEcCtD
Irinotecan—Thrombophlebitis—Carmustine—malignant glioma	0.00114	0.0104	CcSEcCtD
Irinotecan—TOP1—medulla oblongata—malignant glioma	0.00112	0.0308	CbGeAlD
Irinotecan—Thrombophlebitis—Temozolomide—malignant glioma	0.0011	0.0101	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0011	0.01	CcSEcCtD
Irinotecan—Injury—Carmustine—malignant glioma	0.00108	0.0098	CcSEcCtD
Irinotecan—ACHE—telencephalon—malignant glioma	0.00107	0.0293	CbGeAlD
Irinotecan—TOP1—midbrain—malignant glioma	0.00103	0.0282	CbGeAlD
Irinotecan—CES2—medulla oblongata—malignant glioma	0.00102	0.0279	CbGeAlD
Irinotecan—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00101	0.00923	CcSEcCtD
Irinotecan—TOP1—spinal cord—malignant glioma	0.001	0.0275	CbGeAlD
Irinotecan—Hyponatraemia—Carmustine—malignant glioma	0.000993	0.00905	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000989	0.00901	CcSEcCtD
Irinotecan—CES2—midbrain—malignant glioma	0.00093	0.0255	CbGeAlD
Irinotecan—SLC22A3—embryo—malignant glioma	0.00091	0.025	CbGeAlD
Irinotecan—CES2—spinal cord—malignant glioma	0.000907	0.0249	CbGeAlD
Irinotecan—Hypokalaemia—Carmustine—malignant glioma	0.0009	0.0082	CcSEcCtD
Irinotecan—Dehydration—Temozolomide—malignant glioma	0.000888	0.0081	CcSEcCtD
Irinotecan—Hypokalaemia—Temozolomide—malignant glioma	0.000869	0.00792	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00086	0.00784	CcSEcCtD
Irinotecan—ACHE—medulla oblongata—malignant glioma	0.000838	0.023	CbGeAlD
Irinotecan—Abdominal distension—Temozolomide—malignant glioma	0.000831	0.00758	CcSEcCtD
Irinotecan—Sweating increased—Temozolomide—malignant glioma	0.000804	0.00733	CcSEcCtD
Irinotecan—Neutropenia—Carmustine—malignant glioma	0.000799	0.00728	CcSEcCtD
Irinotecan—TOP1—cerebellum—malignant glioma	0.000793	0.0218	CbGeAlD
Irinotecan—Neutropenia—Temozolomide—malignant glioma	0.000772	0.00704	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000767	0.00699	CcSEcCtD
Irinotecan—Pneumonia—Carmustine—malignant glioma	0.000766	0.00698	CcSEcCtD
Irinotecan—ACHE—midbrain—malignant glioma	0.000766	0.021	CbGeAlD
Irinotecan—Renal failure—Carmustine—malignant glioma	0.000749	0.00683	CcSEcCtD
Irinotecan—ACHE—spinal cord—malignant glioma	0.000747	0.0205	CbGeAlD
Irinotecan—Weight decreased—Temozolomide—malignant glioma	0.000747	0.00681	CcSEcCtD
Irinotecan—Stomatitis—Carmustine—malignant glioma	0.000743	0.00677	CcSEcCtD
Irinotecan—Pneumonia—Temozolomide—malignant glioma	0.000741	0.00675	CcSEcCtD
Irinotecan—CES2—central nervous system—malignant glioma	0.000736	0.0202	CbGeAlD
Irinotecan—CES2—cerebellum—malignant glioma	0.000719	0.0198	CbGeAlD
Irinotecan—Stomatitis—Temozolomide—malignant glioma	0.000718	0.00654	CcSEcCtD
Irinotecan—Haemoglobin—Carmustine—malignant glioma	0.000687	0.00627	CcSEcCtD
Irinotecan—Haemorrhage—Carmustine—malignant glioma	0.000684	0.00623	CcSEcCtD
Irinotecan—Connective tissue disorder—Carmustine—malignant glioma	0.000672	0.00613	CcSEcCtD
Irinotecan—Haemoglobin—Temozolomide—malignant glioma	0.000664	0.00605	CcSEcCtD
Irinotecan—Haemorrhage—Temozolomide—malignant glioma	0.000661	0.00602	CcSEcCtD
Irinotecan—Visual impairment—Carmustine—malignant glioma	0.000659	0.00601	CcSEcCtD
Irinotecan—Connective tissue disorder—Temozolomide—malignant glioma	0.000649	0.00592	CcSEcCtD
Irinotecan—TOP1—brain—malignant glioma	0.000644	0.0177	CbGeAlD
Irinotecan—Visual impairment—Temozolomide—malignant glioma	0.000637	0.00581	CcSEcCtD
Irinotecan—Flushing—Carmustine—malignant glioma	0.000635	0.00579	CcSEcCtD
Irinotecan—Cardiac disorder—Temozolomide—malignant glioma	0.000613	0.00559	CcSEcCtD
Irinotecan—Flushing—Temozolomide—malignant glioma	0.000613	0.00559	CcSEcCtD
Irinotecan—ABCC1—telencephalon—malignant glioma	0.000612	0.0168	CbGeAlD
Irinotecan—Arrhythmia—Carmustine—malignant glioma	0.000611	0.00557	CcSEcCtD
Irinotecan—CES1—central nervous system—malignant glioma	0.000606	0.0166	CbGeAlD
Irinotecan—Alopecia—Carmustine—malignant glioma	0.000604	0.00551	CcSEcCtD
Irinotecan—Angiopathy—Temozolomide—malignant glioma	0.0006	0.00547	CcSEcCtD
Irinotecan—Immune system disorder—Temozolomide—malignant glioma	0.000597	0.00544	CcSEcCtD
Irinotecan—Mediastinal disorder—Temozolomide—malignant glioma	0.000596	0.00543	CcSEcCtD
Irinotecan—Chills—Temozolomide—malignant glioma	0.000593	0.00541	CcSEcCtD
Irinotecan—ACHE—cerebellum—malignant glioma	0.000592	0.0163	CbGeAlD
Irinotecan—BCHE—brainstem—malignant glioma	0.000591	0.0162	CbGeAlD
Irinotecan—CES2—brain—malignant glioma	0.000584	0.016	CbGeAlD
Irinotecan—Alopecia—Temozolomide—malignant glioma	0.000584	0.00532	CcSEcCtD
Irinotecan—Back pain—Carmustine—malignant glioma	0.000576	0.00525	CcSEcCtD
Irinotecan—Back pain—Temozolomide—malignant glioma	0.000557	0.00507	CcSEcCtD
Irinotecan—Anaemia—Carmustine—malignant glioma	0.00055	0.00502	CcSEcCtD
Irinotecan—Ill-defined disorder—Temozolomide—malignant glioma	0.000534	0.00487	CcSEcCtD
Irinotecan—Leukopenia—Carmustine—malignant glioma	0.000533	0.00486	CcSEcCtD
Irinotecan—Anaemia—Temozolomide—malignant glioma	0.000532	0.00485	CcSEcCtD
Irinotecan—BCHE—telencephalon—malignant glioma	0.000524	0.0144	CbGeAlD
Irinotecan—Malaise—Temozolomide—malignant glioma	0.000519	0.00473	CcSEcCtD
Irinotecan—Vertigo—Temozolomide—malignant glioma	0.000517	0.00471	CcSEcCtD
Irinotecan—Leukopenia—Temozolomide—malignant glioma	0.000515	0.00469	CcSEcCtD
Irinotecan—ABCB1—blood vessel—malignant glioma	0.000515	0.0141	CbGeAlD
Irinotecan—Hypertension—Carmustine—malignant glioma	0.000514	0.00468	CcSEcCtD
Irinotecan—ABCG2—telencephalon—malignant glioma	0.000506	0.0139	CbGeAlD
Irinotecan—Cough—Temozolomide—malignant glioma	0.000502	0.00458	CcSEcCtD
Irinotecan—Hypertension—Temozolomide—malignant glioma	0.000497	0.00453	CcSEcCtD
Irinotecan—Confusional state—Carmustine—malignant glioma	0.00049	0.00447	CcSEcCtD
Irinotecan—Oedema—Carmustine—malignant glioma	0.000486	0.00443	CcSEcCtD
Irinotecan—Discomfort—Temozolomide—malignant glioma	0.000484	0.00441	CcSEcCtD
Irinotecan—Infection—Carmustine—malignant glioma	0.000483	0.0044	CcSEcCtD
Irinotecan—CES1—brain—malignant glioma	0.000481	0.0132	CbGeAlD
Irinotecan—ACHE—brain—malignant glioma	0.000481	0.0132	CbGeAlD
Irinotecan—Thrombocytopenia—Carmustine—malignant glioma	0.000476	0.00434	CcSEcCtD
Irinotecan—Confusional state—Temozolomide—malignant glioma	0.000473	0.00432	CcSEcCtD
Irinotecan—Oedema—Temozolomide—malignant glioma	0.00047	0.00428	CcSEcCtD
Irinotecan—Anaphylactic shock—Temozolomide—malignant glioma	0.00047	0.00428	CcSEcCtD
Irinotecan—Infection—Temozolomide—malignant glioma	0.000466	0.00425	CcSEcCtD
Irinotecan—Anorexia—Carmustine—malignant glioma	0.000463	0.00422	CcSEcCtD
Irinotecan—Nervous system disorder—Temozolomide—malignant glioma	0.00046	0.0042	CcSEcCtD
Irinotecan—Thrombocytopenia—Temozolomide—malignant glioma	0.00046	0.00419	CcSEcCtD
Irinotecan—Hypotension—Carmustine—malignant glioma	0.000454	0.00414	CcSEcCtD
Irinotecan—Hyperhidrosis—Temozolomide—malignant glioma	0.000454	0.00414	CcSEcCtD
Irinotecan—Anorexia—Temozolomide—malignant glioma	0.000448	0.00408	CcSEcCtD
Irinotecan—Insomnia—Carmustine—malignant glioma	0.000439	0.00401	CcSEcCtD
Irinotecan—Paraesthesia—Carmustine—malignant glioma	0.000436	0.00398	CcSEcCtD
Irinotecan—Dyspnoea—Carmustine—malignant glioma	0.000433	0.00395	CcSEcCtD
Irinotecan—Somnolence—Carmustine—malignant glioma	0.000432	0.00394	CcSEcCtD
Irinotecan—Insomnia—Temozolomide—malignant glioma	0.000425	0.00387	CcSEcCtD
Irinotecan—Decreased appetite—Carmustine—malignant glioma	0.000422	0.00385	CcSEcCtD
Irinotecan—Paraesthesia—Temozolomide—malignant glioma	0.000422	0.00384	CcSEcCtD
Irinotecan—SLC22A3—central nervous system—malignant glioma	0.000421	0.0115	CbGeAlD
Irinotecan—Gastrointestinal disorder—Carmustine—malignant glioma	0.000419	0.00382	CcSEcCtD
Irinotecan—Dyspnoea—Temozolomide—malignant glioma	0.000419	0.00382	CcSEcCtD
Irinotecan—Somnolence—Temozolomide—malignant glioma	0.000417	0.0038	CcSEcCtD
Irinotecan—Pain—Carmustine—malignant glioma	0.000416	0.00379	CcSEcCtD
Irinotecan—Constipation—Carmustine—malignant glioma	0.000416	0.00379	CcSEcCtD
Irinotecan—Dyspepsia—Temozolomide—malignant glioma	0.000413	0.00377	CcSEcCtD
Irinotecan—BCHE—medulla oblongata—malignant glioma	0.000412	0.0113	CbGeAlD
Irinotecan—Decreased appetite—Temozolomide—malignant glioma	0.000408	0.00372	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000405	0.00369	CcSEcCtD
Irinotecan—Fatigue—Temozolomide—malignant glioma	0.000405	0.00369	CcSEcCtD
Irinotecan—Constipation—Temozolomide—malignant glioma	0.000402	0.00366	CcSEcCtD
Irinotecan—Pain—Temozolomide—malignant glioma	0.000402	0.00366	CcSEcCtD
Irinotecan—Feeling abnormal—Carmustine—malignant glioma	0.0004	0.00365	CcSEcCtD
Irinotecan—ABCG2—medulla oblongata—malignant glioma	0.000398	0.0109	CbGeAlD
Irinotecan—Gastrointestinal pain—Carmustine—malignant glioma	0.000397	0.00362	CcSEcCtD
Irinotecan—Feeling abnormal—Temozolomide—malignant glioma	0.000387	0.00353	CcSEcCtD
Irinotecan—Abdominal pain—Carmustine—malignant glioma	0.000384	0.0035	CcSEcCtD
Irinotecan—Body temperature increased—Carmustine—malignant glioma	0.000384	0.0035	CcSEcCtD
Irinotecan—Gastrointestinal pain—Temozolomide—malignant glioma	0.000384	0.0035	CcSEcCtD
Irinotecan—BCHE—midbrain—malignant glioma	0.000376	0.0103	CbGeAlD
Irinotecan—Body temperature increased—Temozolomide—malignant glioma	0.000371	0.00338	CcSEcCtD
Irinotecan—Abdominal pain—Temozolomide—malignant glioma	0.000371	0.00338	CcSEcCtD
Irinotecan—BCHE—spinal cord—malignant glioma	0.000367	0.0101	CbGeAlD
Irinotecan—ABCG2—midbrain—malignant glioma	0.000364	0.00999	CbGeAlD
Irinotecan—Hypersensitivity—Carmustine—malignant glioma	0.000358	0.00326	CcSEcCtD
Irinotecan—ABCG2—spinal cord—malignant glioma	0.000355	0.00974	CbGeAlD
Irinotecan—Asthenia—Carmustine—malignant glioma	0.000349	0.00318	CcSEcCtD
Irinotecan—Hypersensitivity—Temozolomide—malignant glioma	0.000346	0.00315	CcSEcCtD
Irinotecan—ABCC1—cerebellum—malignant glioma	0.00034	0.00933	CbGeAlD
Irinotecan—Asthenia—Temozolomide—malignant glioma	0.000337	0.00307	CcSEcCtD
Irinotecan—ALB—brain—malignant glioma	0.000334	0.00918	CbGeAlD
Irinotecan—SLC22A3—brain—malignant glioma	0.000334	0.00917	CbGeAlD
Irinotecan—Diarrhoea—Carmustine—malignant glioma	0.000332	0.00303	CcSEcCtD
Irinotecan—Dizziness—Carmustine—malignant glioma	0.000321	0.00293	CcSEcCtD
Irinotecan—Diarrhoea—Temozolomide—malignant glioma	0.000321	0.00293	CcSEcCtD
Irinotecan—Dizziness—Temozolomide—malignant glioma	0.000311	0.00283	CcSEcCtD
Irinotecan—Vomiting—Carmustine—malignant glioma	0.000309	0.00282	CcSEcCtD
Irinotecan—ABCB1—embryo—malignant glioma	0.000307	0.00843	CbGeAlD
Irinotecan—Rash—Carmustine—malignant glioma	0.000306	0.00279	CcSEcCtD
Irinotecan—Dermatitis—Carmustine—malignant glioma	0.000306	0.00279	CcSEcCtD
Irinotecan—Headache—Carmustine—malignant glioma	0.000304	0.00277	CcSEcCtD
Irinotecan—Vomiting—Temozolomide—malignant glioma	0.000299	0.00272	CcSEcCtD
Irinotecan—BCHE—central nervous system—malignant glioma	0.000298	0.00818	CbGeAlD
Irinotecan—Rash—Temozolomide—malignant glioma	0.000296	0.0027	CcSEcCtD
Irinotecan—Dermatitis—Temozolomide—malignant glioma	0.000296	0.0027	CcSEcCtD
Irinotecan—Headache—Temozolomide—malignant glioma	0.000294	0.00268	CcSEcCtD
Irinotecan—BCHE—cerebellum—malignant glioma	0.000291	0.00799	CbGeAlD
Irinotecan—Nausea—Carmustine—malignant glioma	0.000289	0.00263	CcSEcCtD
Irinotecan—ABCG2—cerebellum—malignant glioma	0.000281	0.00773	CbGeAlD
Irinotecan—Nausea—Temozolomide—malignant glioma	0.000279	0.00254	CcSEcCtD
Irinotecan—ABCC1—brain—malignant glioma	0.000276	0.00758	CbGeAlD
Irinotecan—ABCB1—retina—malignant glioma	0.000272	0.00746	CbGeAlD
Irinotecan—CYP2B6—central nervous system—malignant glioma	0.000266	0.00729	CbGeAlD
Irinotecan—ABCB1—telencephalon—malignant glioma	0.00025	0.00686	CbGeAlD
Irinotecan—BCHE—brain—malignant glioma	0.000236	0.00649	CbGeAlD
Irinotecan—ABCG2—brain—malignant glioma	0.000229	0.00628	CbGeAlD
Irinotecan—CYP2B6—brain—malignant glioma	0.000211	0.00579	CbGeAlD
Irinotecan—CYP3A4—central nervous system—malignant glioma	0.000201	0.00551	CbGeAlD
Irinotecan—ABCB1—medulla oblongata—malignant glioma	0.000196	0.00539	CbGeAlD
Irinotecan—ABCB1—midbrain—malignant glioma	0.000179	0.00492	CbGeAlD
Irinotecan—ABCB1—spinal cord—malignant glioma	0.000175	0.0048	CbGeAlD
Irinotecan—ABCB1—central nervous system—malignant glioma	0.000142	0.0039	CbGeAlD
Irinotecan—ABCB1—cerebellum—malignant glioma	0.000139	0.00381	CbGeAlD
Irinotecan—ABCB1—brain—malignant glioma	0.000113	0.00309	CbGeAlD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.42e-05	0.000123	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—F2—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—FN1—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CXCL8—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTP1—malignant glioma	1.41e-05	0.000122	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CAT—malignant glioma	1.4e-05	0.000121	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CG—malignant glioma	1.4e-05	0.000121	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PDGFB—malignant glioma	1.4e-05	0.000121	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.39e-05	0.00012	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGFR1—malignant glioma	1.39e-05	0.00012	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTT1—malignant glioma	1.38e-05	0.000119	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HIF1A—malignant glioma	1.37e-05	0.000118	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CAT—malignant glioma	1.37e-05	0.000118	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NCOR1—malignant glioma	1.36e-05	0.000118	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PPARG—malignant glioma	1.35e-05	0.000117	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CG—malignant glioma	1.35e-05	0.000117	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.35e-05	0.000117	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTT1—malignant glioma	1.35e-05	0.000116	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EGF—malignant glioma	1.34e-05	0.000116	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PTPN11—malignant glioma	1.33e-05	0.000115	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NCOR1—malignant glioma	1.33e-05	0.000115	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—IDH1—malignant glioma	1.32e-05	0.000115	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.32e-05	0.000114	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CAV1—malignant glioma	1.32e-05	0.000114	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.31e-05	0.000114	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTP1—malignant glioma	1.3e-05	0.000113	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NCOR1—malignant glioma	1.29e-05	0.000112	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTP1—malignant glioma	1.29e-05	0.000112	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS1—malignant glioma	1.29e-05	0.000112	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SPHK1—malignant glioma	1.28e-05	0.000111	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CAT—malignant glioma	1.27e-05	0.00011	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS1—malignant glioma	1.26e-05	0.000109	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CAT—malignant glioma	1.26e-05	0.000109	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2C18—malignant glioma	1.26e-05	0.000109	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ASMT—malignant glioma	1.25e-05	0.000108	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BAD—malignant glioma	1.24e-05	0.000108	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT2—malignant glioma	1.24e-05	0.000107	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOTCH1—malignant glioma	1.23e-05	0.000107	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CD—malignant glioma	1.23e-05	0.000107	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.23e-05	0.000106	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.22e-05	0.000106	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CAV1—malignant glioma	1.21e-05	0.000105	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD80—malignant glioma	1.21e-05	0.000104	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.21e-05	0.000104	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—malignant glioma	1.2e-05	0.000104	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—BCHE—malignant glioma	1.2e-05	0.000104	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NCOR1—malignant glioma	1.2e-05	0.000103	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGF—malignant glioma	1.19e-05	0.000103	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CD—malignant glioma	1.19e-05	0.000103	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.19e-05	0.000103	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NCOR1—malignant glioma	1.19e-05	0.000103	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.18e-05	0.000102	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTPN11—malignant glioma	1.18e-05	0.000102	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCAN—malignant glioma	1.18e-05	0.000102	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—BCHE—malignant glioma	1.17e-05	0.000101	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.17e-05	0.000101	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTT1—malignant glioma	1.16e-05	0.0001	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.16e-05	0.0001	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.16e-05	0.0001	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CAV1—malignant glioma	1.15e-05	9.94e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CAV1—malignant glioma	1.15e-05	9.94e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BRAF—malignant glioma	1.13e-05	9.8e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CAV1—malignant glioma	1.11e-05	9.58e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CG—malignant glioma	1.1e-05	9.54e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT2—malignant glioma	1.1e-05	9.54e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.1e-05	9.49e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS1—malignant glioma	1.09e-05	9.39e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.08e-05	9.35e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CAV1—malignant glioma	1.08e-05	9.34e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CB—malignant glioma	1.07e-05	9.29e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PPARG—malignant glioma	1.06e-05	9.21e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—malignant glioma	1.06e-05	9.2e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RAF1—malignant glioma	1.06e-05	9.17e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CD—malignant glioma	1.06e-05	9.16e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.06e-05	9.15e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CAV1—malignant glioma	1.05e-05	9.11e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CG—malignant glioma	1.05e-05	9.05e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.05e-05	9.05e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CB—malignant glioma	1.04e-05	8.96e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.03e-05	8.93e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTT1—malignant glioma	1.02e-05	8.78e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGF2—malignant glioma	1.01e-05	8.77e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PPARG—malignant glioma	1.01e-05	8.74e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPARG—malignant glioma	1.01e-05	8.74e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—BCHE—malignant glioma	1.01e-05	8.73e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CG—malignant glioma	1.01e-05	8.73e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.01e-05	8.7e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1e-05	8.65e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC5A5—malignant glioma	9.97e-06	8.62e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.85e-06	8.52e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CG—malignant glioma	9.84e-06	8.51e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CAV1—malignant glioma	9.75e-06	8.43e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPARG—malignant glioma	9.74e-06	8.42e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CD—malignant glioma	9.7e-06	8.39e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CAV1—malignant glioma	9.66e-06	8.36e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CG—malignant glioma	9.59e-06	8.29e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—malignant glioma	9.54e-06	8.25e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS1—malignant glioma	9.51e-06	8.23e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—malignant glioma	9.51e-06	8.23e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPARG—malignant glioma	9.5e-06	8.21e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MDM2—malignant glioma	9.49e-06	8.21e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—IDH2—malignant glioma	9.49e-06	8.2e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RAF1—malignant glioma	9.46e-06	8.18e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.43e-06	8.15e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—malignant glioma	9.36e-06	8.09e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.34e-06	8.08e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—malignant glioma	9.32e-06	8.06e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAT—malignant glioma	9.28e-06	8.03e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—malignant glioma	9.28e-06	8.02e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPARG—malignant glioma	9.26e-06	8.01e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CB—malignant glioma	9.23e-06	7.99e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CD—malignant glioma	9.2e-06	7.96e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CD—malignant glioma	9.2e-06	7.96e-05	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	9.18e-06	7.94e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—malignant glioma	9.15e-06	7.91e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAT—malignant glioma	9.07e-06	7.85e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.92e-06	7.71e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—malignant glioma	8.88e-06	7.68e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—malignant glioma	8.87e-06	7.67e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BCHE—malignant glioma	8.84e-06	7.65e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—malignant glioma	8.8e-06	7.61e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NCOR1—malignant glioma	8.77e-06	7.58e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—malignant glioma	8.73e-06	7.55e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—malignant glioma	8.65e-06	7.48e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPARG—malignant glioma	8.57e-06	7.41e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NCOR1—malignant glioma	8.57e-06	7.41e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPARG—malignant glioma	8.49e-06	7.35e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—malignant glioma	8.45e-06	7.31e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—malignant glioma	8.43e-06	7.29e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—malignant glioma	8.37e-06	7.24e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—IDH1—malignant glioma	8.16e-06	7.05e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.15e-06	7.05e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—malignant glioma	8.08e-06	6.99e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.04e-06	6.96e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—malignant glioma	8.03e-06	6.95e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—malignant glioma	8.02e-06	6.94e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—malignant glioma	8.02e-06	6.94e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—malignant glioma	7.98e-06	6.9e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—malignant glioma	7.95e-06	6.87e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—malignant glioma	7.95e-06	6.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SPHK1—malignant glioma	7.89e-06	6.83e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAT—malignant glioma	7.81e-06	6.76e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—malignant glioma	7.81e-06	6.75e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—malignant glioma	7.74e-06	6.69e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—malignant glioma	7.73e-06	6.69e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.73e-06	6.69e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—malignant glioma	7.66e-06	6.63e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—malignant glioma	7.54e-06	6.52e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—malignant glioma	7.47e-06	6.46e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NCOR1—malignant glioma	7.38e-06	6.38e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—malignant glioma	7.35e-06	6.36e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—malignant glioma	7.3e-06	6.32e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—malignant glioma	7.28e-06	6.3e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAV1—malignant glioma	7.15e-06	6.18e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—malignant glioma	7.14e-06	6.17e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—malignant glioma	7.04e-06	6.09e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAV1—malignant glioma	6.98e-06	6.04e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—malignant glioma	6.93e-06	5.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—malignant glioma	6.93e-06	5.99e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—malignant glioma	6.87e-06	5.94e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAT—malignant glioma	6.85e-06	5.92e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—malignant glioma	6.8e-06	5.88e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—malignant glioma	6.74e-06	5.83e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—malignant glioma	6.74e-06	5.83e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—malignant glioma	6.68e-06	5.78e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—malignant glioma	6.68e-06	5.78e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—malignant glioma	6.63e-06	5.73e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—malignant glioma	6.54e-06	5.66e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—malignant glioma	6.51e-06	5.63e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.51e-06	5.63e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—malignant glioma	6.49e-06	5.61e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NCOR1—malignant glioma	6.47e-06	5.59e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—malignant glioma	6.36e-06	5.5e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—malignant glioma	6.35e-06	5.49e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—malignant glioma	6.31e-06	5.46e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARG—malignant glioma	6.28e-06	5.43e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—malignant glioma	6.25e-06	5.41e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARG—malignant glioma	6.14e-06	5.31e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—malignant glioma	6.13e-06	5.3e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—malignant glioma	6.11e-06	5.28e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAV1—malignant glioma	6.02e-06	5.2e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—malignant glioma	5.88e-06	5.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS1—malignant glioma	5.86e-06	5.07e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—malignant glioma	5.83e-06	5.04e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.75e-06	4.97e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—malignant glioma	5.72e-06	4.95e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—malignant glioma	5.63e-06	4.87e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—malignant glioma	5.59e-06	4.84e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—malignant glioma	5.48e-06	4.74e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCHE—malignant glioma	5.45e-06	4.71e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.38e-06	4.65e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—malignant glioma	5.35e-06	4.62e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARG—malignant glioma	5.29e-06	4.57e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAV1—malignant glioma	5.27e-06	4.56e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—malignant glioma	5.16e-06	4.46e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—malignant glioma	5.15e-06	4.46e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.99e-06	4.31e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—malignant glioma	4.94e-06	4.27e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—malignant glioma	4.89e-06	4.23e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—malignant glioma	4.89e-06	4.23e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—malignant glioma	4.88e-06	4.22e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—malignant glioma	4.83e-06	4.18e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—malignant glioma	4.82e-06	4.17e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—malignant glioma	4.8e-06	4.15e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—malignant glioma	4.71e-06	4.08e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARG—malignant glioma	4.63e-06	4.01e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—malignant glioma	4.6e-06	3.98e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—malignant glioma	4.6e-06	3.98e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—malignant glioma	4.48e-06	3.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—malignant glioma	4.33e-06	3.75e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—malignant glioma	4.31e-06	3.73e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—malignant glioma	4.22e-06	3.65e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAT—malignant glioma	4.22e-06	3.65e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—malignant glioma	4.21e-06	3.64e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—malignant glioma	4.21e-06	3.64e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—malignant glioma	4.2e-06	3.63e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—malignant glioma	4.16e-06	3.6e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—malignant glioma	4.15e-06	3.59e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.11e-06	3.56e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—malignant glioma	3.99e-06	3.45e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—malignant glioma	3.99e-06	3.45e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOR1—malignant glioma	3.98e-06	3.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—malignant glioma	3.85e-06	3.33e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—malignant glioma	3.75e-06	3.25e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—malignant glioma	3.68e-06	3.18e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—malignant glioma	3.66e-06	3.17e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—malignant glioma	3.64e-06	3.15e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—malignant glioma	3.63e-06	3.14e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—malignant glioma	3.39e-06	2.93e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—malignant glioma	3.36e-06	2.9e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAV1—malignant glioma	3.25e-06	2.81e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—malignant glioma	3.18e-06	2.75e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.04e-06	2.63e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.97e-06	2.57e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.96e-06	2.56e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARG—malignant glioma	2.85e-06	2.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.6e-06	2.25e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—malignant glioma	2.56e-06	2.21e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—malignant glioma	2.48e-06	2.15e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—malignant glioma	2.43e-06	2.1e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.27e-06	1.96e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—malignant glioma	2.25e-06	1.94e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—malignant glioma	2.24e-06	1.94e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—malignant glioma	2.09e-06	1.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—malignant glioma	1.96e-06	1.69e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—malignant glioma	1.83e-06	1.58e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.38e-06	1.19e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—malignant glioma	1.13e-06	9.76e-06	CbGpPWpGaD
